Lessons Learned And What's Ahead: I-Mab, JW, RemeGen CEOs On Biotech Financing

JPM Panel Discusses Issues And Options

 
• By Brian Yang
  
CHINA BIOTECH IPO AND FUNDRAISING DISCUSSED BY JPM PANEL • Source: Shutterstock

More from China

More from Focus On Asia